Delisting riskPopularity #4,364
JSPR · NASDAQ · Biotechnology

Jasper Therapeutics (JSPR)

Develops complement inhibitors and targeted antibodies for immunological disorders.

$0.6248
vs last close+0.02 (+3.67%)